Search the site
Court Proceedings
This was an appeal of a decision on a motion to strike certain portions of Bell Canada's Statement of Defence and Counterclaim. Initially the case management judge struck portions of Bell Canada's claims against our clients, the Plaintiffs/Defendants by Counterclaim and Aird & Berlis. That decision was appealed by Bell Canada. The Federal Court judge dismissed the appeal and determined that the case management judge was correct in dismissing certain claims against the Plaintiffs/Defendants by Counterclaim and Aird & Berlis including claims related to alleged misuse of copyright and unlawful means conspiracy.
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,496,249 (linagliptin).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,557,801, 2,606,650, 2,751,833 and 2,813,661 (empagliflozin).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,738,367 (linagliptin).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,696,558 (linagliptin).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,782,179 (linagliptin).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,472,399, 2,590,511 and 2,703,598 (sacubitril/valsartan)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,732,803 (linagliptin).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,649,922 (linagliptin).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,696,558 and 2,752,435 (empagliflozin).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,936,852, 2,485,143, 2,544,621 and 2,781,799 (riociguat)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,752,437 (linagliptin).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,845,553 (tenofovir alafenamide).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,845,553 and 2,990,210 (tenofovir alafenamide/emtricitabine).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,731,370 and 2,764,475 (selexipag).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,731,370 and 2,764,475 (selexipag).
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,589,765, 2,589,921, 2,701,778, 2,741,312 and 2,873,044 (carfilzomib).
Motion to strike portions of the Amended Statement of Defence and Counterclaim w.r.t. ss. 41.25 and 41.26 of the Copyright Act.
Actions under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,450,740, No. 2,529,400 and No. 2,536,251 as well as patent infringement actions relating to Patent No. 2,518,435 with respect to products containing sitagliptin and products containing both sitagliptin and metformin.
Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,682,598 with respect to products containing sapropterin.
Action for copyright infringement. Acting as counsel on motions relating to the Statement of Claim and appeals therefrom.
Trademark expungement case regarding Registration Nos. TMA617,580 and TMA638,321 (TUSCANI)
Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent Nos. 2,440,472, 2,521,885, and 2,803,922 (doxycycline)
Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent Nos. 2,621,273 and 2,659,770 (macitentan)
Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,402,894 (saxagliptin)
Application for leave to appeal to the Supreme Court of Canada in a patent impeachment action relating to Patent No. 2,261,630 (infliximab)
Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,752,550 (pomalidomide)
Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,794,060 (pomalidomide)
Trademark expungement case regarding Registration No. TMA381,146 (LIMCA)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,791,171 (apixaban)
Appeal of a trademark expungement case regarding Registration Nos. TMDA22577 and UCA44562 (HORLICKS)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,461,202 (apixaban)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,344,318 and 2,743,326 (daptomycin)
Patent infringement regarding Patent No. 2,743,326 (daptomycin)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,762,013 and 2,620,380 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,709,997 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,620,380 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,667,654 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,937,365 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,631,646 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,710,014 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,710,358 (pirfenidone)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,819,967 (pirfenidone)
Interlocutory appeal in a patent impeachment action relating to Patent No. 2,261,630 (infliximab)
Trademark opposition case regarding Registration No. 1,691,811 (INSTA-LOC)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,507,002 and 2,496,780 (silodosin)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,823,159, 2,634,310 and 2,547,113 (rivaroxaban)
Motion/Application under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,540,547, 2,596,133, 2,376,596 and 2,407,556 (trastuzumab)
Action under the Trademarks Act and the Competition Act regarding Registration Nos. TMA580,557 (ENERGIZER MAX), TMA157,162 (ENERGIZER) and TMA740,338 (ENERGIZER)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,540,547, 2,596,133, 2,376,596 and 2,407,556 (trastuzumab)
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,540,547, 2,596,133, 2,376,596 and 2,407,556 (trastuzumab)
Statutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)
Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)
Appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)
Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)
Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)
Trademark infringement action against the owner of a s. 9 mark
CIRA domain name dispute relating to the domain name STRIPMEISTER.CA
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,823,159, 2,634,310 and 2,547,113 (rivaroxaban)
Trademark expungement regarding Registration Nos. TMDA22577 and UCA44562 (HORLICKS)
Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,477,301, 2,688,709, 2,476,983, 2,688,694, 2,537,092, 2,687,927, 2,688,695, 2,741,575, 2,688,708, 2,687,924 and 2,741,412 (lenalidomide)
Trademark expungement regarding Registration No. TMA400474 (RED BARN)
Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,415,403 (acetaminophen)
Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,705,733 (acetaminophen)
Patent infringement case regarding Patent No. 2,407,556 (trastuzumab)
Patent impeachment case regarding Patent No. 2,540,547 (trastuzumab)
Patent impeachment case regarding Patent No. 2,329,829 (trastuzumab)
Patent impeachment case regarding Patent No. 2,376,596 (trastuzumab)
Patent infringement case regarding Patent No. 2,787,952 (bevacizumab) with counterclaim for infringement under the new Patented Medicines (Notice of Compliance) Regulations
Patent impeachment case regarding Patent No. 2,596,133 (trastuzumab)
Interlocutory decision in a trademark infringement action
Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,366,785 and 2,476,934 (etanercept)
Appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)
Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)
Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)
Application under s. 18.1 of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,586,023 (sevelamer)
Patent infringement case regarding Patent Nos. 2,475,076 and 2,522,321 (Hard Wood Floor Panels and Manufacturing)
Patent infringement case regarding Patent No. 2,677,529 (Mobile Airborne Contaminant Control Chamber)
Action under the Trademarks Act and the Competition Act regarding Registration Nos. TMA580,557 (ENERGIZER MAX), 157,162 (ENERGIZER) and 740,338 (ENERGIZER)
Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)
Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,261,630 (infliximab).
Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,166,483, 2,186,037, 1,338,377, 2,133762, 2,170,647, 2,290,963, 2,346,988, 2,166,794, 2,139,653, 2,180,535, 2,290,531, 2,226,184 and 2,193,994 (esomeprazole)
Trademark infringement case regarding Registration No. TMA396,079 (FREEDOMWALKER)
Trademark infringement case regarding Registration No. TMA396,079 (FREEDOMWALKER)
Trademark opposition case regarding Registration No. 1,172,524 (DEMERARA)
Application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 1,340,794 and 2,031,890 (pemetrexed).
Action under section 8 of the old Patented Medicines (Notice of Compliance) Regulations regarding patent No. 2,327,285, 2,325,045, 2,297,163 and 2,134,674 (pregabalin).
Judicial review application regarding Patent No. 2,261,630 (infliximab)
Trademark infringement case regarding Registration No. TMA 624,752 (PINK)
Patent impeachement and patent infringement case regarding Patent No. 2,261,630 (infliximab).
Patent infringement case regarding Patent No. 2,355,347 (quinapril)
Patent infringement case regarding Patent No. 1,336,777 (clopidogrel).
Patent infringement case regarding Patent No. 1,336,777 (clopidogrel).
Appeal in a patent infringement case regarding Patent No. 1,340,083 (valacyclovir).
Appeal in a patent infringement case regarding Patent No. 1,340,083 (valacyclovir).
Appeal of an application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,372,576 and 2,219,475 (fenofibrate)
Appeal of an application under subsection 6(1) the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,372,576 and 2,219,475 (fenofibrate)
Appeal of an application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,487,054 (fenofibrate)
Appeal of an application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,487,054 (fenofibrate)
Appeal of an application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,487,054 (fenofibrate)
